ABSTRACT
Reveals important new results from clinical trials conducted in Scandinavia, Scotland, Australia, Canada, and the United States.
This timely reference reviews the vast body of clinical trial evidence supporting the once controversial view that high levels of serum cholesterol are a major risk factor in coronary heart disease (CHD). The studies p
TABLE OF CONTENTS
chapter 3|28 pages
Cholesterol and Recurrent Events Trial (CARE): The Effect of Pravastatin on Coronary Events After Myocardial Infarction in Patients with Average Cholesterol Levels
Trial Effect Pravastatin Coronary Events After Myocardial Infarction Patients Average Cholesterol Levels
chapter 5|56 pages
Program on the Surgical Control of the Hyperlipidemias (POSCH) Trial: A Pivotal 25-Year Study
Trial Pivotal 25-Year Study
chapter 7|18 pages
Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study: Clinical Implications for Cardiovascular Practice
Study Clinical Implications Cardiovascular Practice
chapter 8|30 pages
Angiographic Results of Lipid-Lowering Trials: A Systematic Review and Meta-Analysis
Trials Systematic Review Meta-Analysis
chapter 10|24 pages
Lipid Therapy to Stabilize the Vulnerable Atherosclerotic Plaque: New Insights into the Prevention of Cardiovascular Events
Prevention Cardiovascular Events
